About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | High-Dose Therapy Treatment in Patients With Follicular Lymphoma

High-Dose Therapy Treatment in Patients With Follicular Lymphoma

NCT00696735·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

French Innovative Leukemia Organisation

Age 8-60 years old follicular lymphoma Not previously treated Stage II bulky, III or IV An Arbor classification high tumor burden

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age 18-60 years old
Follicular Lymphoma B, C or D (Working Formulation)
No previous treatment
Seronegativity HIV
ECOG performance status less than or 2
eligible for autologous stem-cell transplantation
Stage II , III or IV Ann Arbor Classification
criterias of high tumor burden
Patient's written informed consent

You may not be if

Age less than 18 years old or more than 60 years old
Other type of lymphoma
Stage less than 3 or III-IV (faible masse)
Seropositivity HIV
Patients with a history of another malignancy except basal cell skin cancer or in situ uterus cancer

The record

StatusCompleted

PhasePhase 3

Taking part172

StartedJun 1994

UpdatedOct 24, 2008

Conditions

Follicular Lymphoma

Where2

Emmanuel GYAN
Tours, France
Philippe COLOMBAT
Tours, France